Downregulation of PAQR3 expression predicts poor prognosis of patients with pan-cancer: a meta-analysis
This study aimed to evaluate the association between progestin and adipoQ receptor 3 (PAQR3) expression and survival outcomes, as well as disease progression, through a meta-analysis. A systematic literature search was conducted across multiple academic databases, including Cochrane Library, Embase,...
Saved in:
| Main Authors: | Kui Zhai, Xing-Peng Miao, Shi-Gui Ai, Qiang Guo, Ren-Zhong Zha |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1574150/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biochemical characterization of zebrafish Paqr5b
by: Md Sohanur Rahman Sohan, et al.
Published: (2025-06-01) -
Chicoric acid advanced PAQR3 ubiquitination to ameliorate ferroptosis in diabetes nephropathy through the relieving of the interaction between PAQR3 and P110α pathway
by: Weiwei Zhang, et al.
Published: (2024-12-01) -
PAQR6 as a prognostic biomarker and potential therapeutic target in kidney renal clear cell carcinoma
by: Tao Zou, et al.
Published: (2024-12-01) -
Transcriptomic and Functional Validation Reveals PAQR3/P6-55 as Potential Therapeutic Targets in Colon Cancer
by: Xue You, et al.
Published: (2025-06-01) -
PAQR5 drives the malignant progression and shapes the immunosuppressive microenvironment of hepatocellular carcinoma by activating the NF-κB signaling
by: Ruida Yang, et al.
Published: (2025-05-01)